​
​

Verve Therapeutics (VERV) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Verve Therapeutics Revenue Highlights

Latest Revenue (Y)

$11.76M

Latest Revenue (Q)

$6.87M

Verve Therapeutics Revenue by Period

Verve Therapeutics Revenue by Year

DateRevenueChange
2023-12-31-505.77%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

Verve Therapeutics generated $11.76M in revenue during NA 2023, up 505.77% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Verve Therapeutics Revenue by Quarter

DateRevenueChange
2024-09-30-2.59%
2024-06-30-17.51%
2024-03-31-10.71%
2023-12-31-65.03%
2023-09-30-48.92%
2023-06-30-49.07%
2023-03-31-38.74%
2022-12-31-8.93%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--

Verve Therapeutics generated $6.87M in revenue during Q3 2024, up 2.59% compared to the previous quarter, and up 328.00% compared to the same period a year ago.

Verve Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
BEAMBeam Therapeutics--
CRSPCRISPR Therapeutics--
BPMCBlueprint Medicines--
ADPTAdaptive Bio--
NTLAIntellia Therapeutics--
CRBUCaribou Biosciences--
RLAYRelay Therapeutics--
VERVVerve Therapeutics--
IPSCCentury Therapeutics--
LIFEaTyr Pharma--
EDITEditas Medicine--
PRMEPrime Medicine--
SANASana Bio--

VERV Revenue FAQ

What is Verve Therapeutics’s yearly revenue?

Verve Therapeutics's yearly revenue for 2023 was $11.76M, representing an increase of 505.77% compared to 2022. The company's yearly revenue for 2022 was $1.94M, representing an increase of 100.00% compared to 2021. VERV's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is Verve Therapeutics’s quarterly revenue?

Verve Therapeutics's quarterly revenue for Q3 2024 was $6.86M, a 2.59% increase from the previous quarter (Q2 2024), and a 120.24% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $6.69M, a 17.51% increase from the previous quarter (Q1 2024), and a 219.73% increase year-over-year (Q2 2023). VERV's quarterly revenue for Q1 2024 was $5.7M, a 10.71% increase from the previous quarter (Q4 2023), and a 305.63% increase year-over-year (Q1 2023).

What is Verve Therapeutics’s revenue growth rate?

Verve Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.